Medical Billers and Coders

Accurate coding for demand ischemia has become a growing concern for hospitals across Texas. As payer scrutiny increases and clinical documentation requirements become more complex, even experienced coding teams can face challenges when assigning the correct ICD-10 code. The distinction between demand ischemia, myocardial injury, and Type 2 myocardial infarction (MI) has significant implications for reimbursement, quality reporting, compliance, and audit risk. Unfortunately, many hospitals continue to experience confusion regarding when demand ischemia should be reported, which diagnosis codes are appropriate, and what documentation must support the coding decision. These uncertainties can lead to claim denials, payment delays, compliance concerns, and inaccurate clinical data. Why Demand Ischemia Coding Creates Challenges Demand ischemia occurs when myocardial oxygen demand exceeds oxygen supply, often due to conditions such as sepsis, severe anemia, respiratory failure, tachyarrh...

Well-woman exams are among the most frequently performed preventive services in women's healthcare. While these visits play an essential role in preventive care, they also present significant billing and coding challenges for providers. As payer requirements continue to evolve, even small coding mistakes can result in denied claims, delayed reimbursement, compliance risks, and lost revenue. Many OBGYN practices assume their preventive visit coding is accurate until they begin experiencing increased denials or payer audits. This raises an important question: Are your Well Woman Exam codes compliant with current billing guidelines? Ensuring compliance requires more than selecting the correct CPT or diagnosis code. Providers must understand payer-specific requirements, preventive service guidelines, documentation standards, and medical necessity rules to protect reimbursement and reduce audit exposure. Why Well Woman Exam Coding Is More Complex Than It Appears At first glance, prevent...

Hospitalist practices face growing reimbursement challenges in 2026. Evaluation and Management (E/M) services remain one of the largest revenue sources for hospital-based providers, yet increasing payer scrutiny, documentation requirements, and coding complexities continue to put reimbursement at risk. Even minor documentation gaps can result in downcoding, denials, underpayments, or audit exposure. As a result, many hospitalist groups are reevaluating their revenue cycle strategies and asking an important question: Which hospitalist billing companies actually protect E/M revenue in 2026? The answer depends on a billing company's ability to strengthen documentation accuracy, reduce denials, optimize coding, and maintain strong Revenue Integrity throughout the revenue cycle. Why E/M Revenue Is Under Pressure in 2026 Hospitalist reimbursement is heavily dependent on E/M coding accuracy. Payers are increasingly reviewing claims for medical necessity, documentation support, physician ...

Neurology practices face unique reimbursement challenges that make revenue protection increasingly difficult in 2026. From complex Evaluation and Management (E/M) coding requirements to diagnostic testing reimbursement rules, even minor billing errors can lead to substantial revenue leakage. Many neurologists are finding that denials, underpayments, coding inaccuracies, and documentation deficiencies are reducing profitability despite maintaining strong patient volumes. As payer scrutiny continues to increase, practices are asking an important question: Which neurology billing companies actually protect your diagnostic and E/M revenue in 2026? The answer depends on a billing company's ability to safeguard reimbursement across the entire revenue cycle, including coding accuracy, denial prevention, diagnostic testing compliance, and revenue integrity monitoring. Why Neurology Billing Is Becoming More Challenging Neurology billing involves far more complexity than many other speci...

Ambulatory Surgery Centers (ASCs) continue to face increasing reimbursement pressure in 2026. Rising denial rates, stricter payer audits, facility fee scrutiny, prior authorization requirements, and evolving Medicare regulations are creating new revenue cycle challenges for surgery centers across the United States. As operational costs rise and margins become tighter, ASC administrators are focusing more closely on billing performance. Many are discovering that revenue leakage often originates within the billing process itself, making the selection of the right billing partner more important than ever. This raises a critical question: Which ASC billing company delivers the best results in 2026? The answer depends on several factors, including specialty expertise, denial management capabilities, revenue integrity programs, payer contract analysis, AR recovery performance, and overall financial outcomes. Why ASC Billing Is More Complex Than Ever ASC reimbursement is significantly differe...

General surgery practices face unique revenue cycle challenges that can significantly impact profitability. From global surgical package rules and modifier usage to prior authorizations and post-operative billing requirements, surgical reimbursement has become increasingly complex. In 2026, rising denial rates, stricter payer audits, and evolving reimbursement policies are forcing many surgeons to evaluate whether their current billing partner is truly delivering optimal results. The question many practice administrators and surgeons are asking is, " Which  general surgery billing company delivers the best results?" The answer depends on a company's ability to improve collections, reduce denials, strengthen compliance, and protect revenue integrity throughout the entire revenue cycle. Why General Surgery Billing Is More Complex Than Ever General surgery billing requires specialized knowledge of surgical coding, global periods, assistant surgeon billing, modifier applicati...